Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 1 - 10 of 688 shown below

  • O'Brien, M E R

    R Mendes, M E R O'Brien, A Mitra, A Norton, R K Gregory, A R Padhani, K V Bromelow, A R Winkley, S Ashley, I E Smith and B E Souberbielle

    Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma

    doi:10.1038/sj.bjc.6600063

  • J S Waters and M E R O'Brien

    The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)

    doi:10.1038/sj.bjc.6600491

  • P J Ross, S Ashley, A Norton, K Priest, J S Waters, T Eisen, I E Smith and M E R O'Brien

    Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

    advance online publication, 2004-04-20 00:00:00.000;

    doi:10.1038/sj.bjc.6601781

  • P J Barrett-Lee, N P Bailey, M E R O'Brien and E Wager

    Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

    doi:10.1054/bjoc.1999.0883

  • O'Brien, S G

    S G O'Brien, P Meinhardt, E Bond, J Beck, B Peng, C Dutreix, G Mehring, S Milosavljev, C Huber, R Capdeville and T Fischer

    Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

    doi:10.1038/sj.bjc.6601152

  • O'Brien, T J

    A D Santin, F Zhan, S Bellone, M Palmieri, S Cane, M Gokden, J J Roman, T J O'Brien, E Tian, M J Cannon, J Shaughnessy and S Pecorelli

    Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

    doi:10.1038/sj.bjc.6601791

  • O'Byrne, J

    J A Glaspy, J S Jadeja, G Justice, J Kessler, D Richards, L Schwartzberg, N S Tchekmedyian, S Armstrong, J O'Byrne, G Rossi and A B Colowick

    Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

    doi:10.1038/sj.bjc.6600465

  • O'Byrne, K J

    K J O'Byrne, A L Thomas, R A Sharma, M DeCatris, F Shields, S Beare and W P Steward

    A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

    doi:10.1038/sj.bjc.6600344

  • J G Edwards, J McLaren, J L Jones, D A Waller and K J O'Byrne

    Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura

    doi:10.1038/sj.bjc.6600920

  • O'Callaghan, A

    P A Whitehouse, S J Mercer, L A Knight, F Di Nicolantonio, A O'Callaghan and I A Cree

    Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C

    doi:10.1038/sj.bjc.6601403

  • O'Connell, J

    A Houston, M W Bennett, G C O'Sullivan, F Shanahan and J O'Connell

    Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression

    doi:10.1038/sj.bjc.6601240

  • O'Doherty, A M

    A M O'Doherty, S W Church, S E H Russell, J Nelson and I Hickey

    Methylation status of oestrogen receptor-alpha gene promoter sequences in human ovarian epithelial cell lines

    doi:10.1038/sj.bjc.6600028

  • O'Donnell, A

    P Beale, I Judson, A O'Donnell, J Trigo, C Rees, F Raynaud, A Turner, L Simmons and L Etterley

    A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)

    doi:10.1038/sj.bjc.6600854

  • O'Donnell, D

    B Ortel, D Sharlin, D O'Donnell, A K Sinha, E V Maytin and T Hasan

    Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells

    doi:10.1038/sj.bjc.6600575